Skip to main content

Interactive Features

Quiz
11/27/2023
Do you know which outcome was less frequent among patients with cholangiocarcinoma with extrahepatic metastases who received liver-directed radiotherapy? Take our quick quiz to find out!
Do you know which outcome was less frequent among patients with cholangiocarcinoma with extrahepatic metastases who received liver-directed radiotherapy? Take our quick quiz to find out!
Do you know which outcome was...
11/27/2023
Oncology
Quiz
11/27/2023
Do you know the results of the real-world analysis of the efficacy of gemcitabine and cisplatin plus durvalumab among patients with advanced biliary tract cancer? Take our quick quiz to find out!
Do you know the results of the real-world analysis of the efficacy of gemcitabine and cisplatin plus durvalumab among patients with advanced biliary tract cancer? Take our quick quiz to find out!
Do you know the results of the...
11/27/2023
Oncology
Quiz
07/20/2023
What was the response rate among patients with locally advanced or metastatic IDH1/2 mutant cholangiocarcina who received the dual IDH1/2 inhibitor LY3410738 in combination with cisplatin-gemcitabine?
What was the response rate among patients with locally advanced or metastatic IDH1/2 mutant cholangiocarcina who received the dual IDH1/2 inhibitor LY3410738 in combination with cisplatin-gemcitabine?
What was the response rate among...
07/20/2023
Oncology
Quiz
06/15/2023
True or False: Patients with non-metastatic cholangiocarcinoma who received adjuvant or neoadjuvant chemotherapy had better median overall survival compared to patients who had surgery only.
True or False: Patients with non-metastatic cholangiocarcinoma who received adjuvant or neoadjuvant chemotherapy had better median overall survival compared to patients who had surgery only.
True or False: Patients with...
06/15/2023
Oncology
Quiz
06/15/2023
True or False: Patients with non-metastatic cholangiocarcinoma who received adjuvant or neoadjuvant chemotherapy had better median overall survival compared to patients who had surgery only.
True or False: Patients with non-metastatic cholangiocarcinoma who received adjuvant or neoadjuvant chemotherapy had better median overall survival compared to patients who had surgery only.
True or False: Patients with...
06/15/2023
Oncology
Quiz
06/15/2023
When used to diagnose cholangiocarcinoma, or bile duct cancer, cholangioscopy yields a sensitivity of about ___.
When used to diagnose cholangiocarcinoma, or bile duct cancer, cholangioscopy yields a sensitivity of about ___.
When used to diagnose...
06/15/2023
Oncology
Quiz
06/15/2023
When used to diagnose cholangiocarcinoma, or bile duct cancer, cholangioscopy yields a sensitivity of about ___.
When used to diagnose cholangiocarcinoma, or bile duct cancer, cholangioscopy yields a sensitivity of about ___.
When used to diagnose...
06/15/2023
Oncology
Quiz
05/09/2023
In what percentage of patients with cholangiocarcinoma does an IDH mutation occur?
In what percentage of patients with cholangiocarcinoma does an IDH mutation occur?
In what percentage of patients...
05/09/2023
Oncology
Quiz
05/09/2023
In what percentage of patients with cholangiocarcinoma does an IDH mutation occur?
In what percentage of patients with cholangiocarcinoma does an IDH mutation occur?
In what percentage of patients...
05/09/2023
Oncology
Quiz
04/11/2023
Which type of biliary tract cancer is more likely to be IDH-mutant?
Which type of biliary tract cancer is more likely to be IDH-mutant?
Which type of biliary tract...
04/11/2023
Oncology